SCHEMBL1421695

SCHEMBL1421695

CCOc1ccc(/C=C2\SC(=O)N(c3ccc(F)cc3)C2=O)cc1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.71
▸ KMT2A Q03164 8/20 0.71
▸ MAPT P10636 6/20 0.71
▸ FAAH O00519 1/20 0.65
▸ IDE P14735 2/20 0.64
▸ MCL1 Q07820 2/20 0.64
▸ POLB P06746 2/20 0.58
▸ LMNA P02545 1/20 0.58
▸ HTT P42858 1/20 0.58
▸ BLM P54132 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ HSD17B3 P37058 1/20 0.53
▸ THRB P10828 1/20 0.51
▸ DUSP3 P51452 1/20 0.51
▸ PTPN5 P54829 1/20 0.51
▸ PTPN11 Q06124 1/20 0.51
▸ CTDSP1 Q9GZU7 1/20 0.51
▸ SAE1 Q9UBE0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1421701 1.00 MEN1 (0.71) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1421699 1.00 MEN1 (0.71) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1641528 0.92 MEN1 (0.84) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1421174 0.92 MEN1 (0.84) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1421308 0.90 FAAH (0.62) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1421306 0.90 FAAH (0.62) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1421307 0.90 FAAH (0.62) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1421182 0.90 MEN1 (0.71) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1421179 0.90 MEN1 (0.71) MEN1KMT2AMAPTFAAHIDE
SCHEMBL1421183 0.90 MEN1 (0.71) MEN1KMT2AMAPTFAAHIDE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110098323-A1 INHIBITORS OF BACTERIAL BIOFILM FORMATION MICROBIOTIX, INC. (US) 2011-04-28 — — US claimed
EP-2296476-A1 INHIBITORS OF BACTERIAL BIOFILM FORMATION Microbiotix, Inc. (US) 2011-03-23 — — EP claimed
WO-2009142720-A1 INHIBITORS OF BACTERIAL BIOFILM FORMATION MICROBIOTIX, INC. (US) 2009-11-26 — — WO claimed
US-20110098323-A1 INHIBITORS OF BACTERIAL BIOFILM FORMATION MICROBIOTIX, INC. (US) 2011-04-28 — — US disclosed
EP-2296476-A1 INHIBITORS OF BACTERIAL BIOFILM FORMATION Microbiotix, Inc. (US) 2011-03-23 — — EP disclosed
WO-2009142720-A1 INHIBITORS OF BACTERIAL BIOFILM FORMATION MICROBIOTIX, INC. (US) 2009-11-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098323-A1 INHIBITORS OF BACTERIAL BIOFILM FORMATION BLVRB, TFPI, FOSB MEN1 4836/4885KMT2A 3896/4885MAPT 4065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback